• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

The family dispute in Ranbaxy family seems to be impacting sentiment in the counter, dealers said. On Thursday, Ranbaxy closed at Rs 354.70, down from previous close of Rs 357.40.

Though the dispute has nothing to do with Ranbaxy Laboratories and its functioning, dealers said the dispute in the family has raised doubts among investors on the stature of the company.

A recent report by a foreign brokerage firm also has urged investors to dump Ranbaxy in favour of Dr Reddy's in pharma space, dealers said.

Rajesh Abraham

More Stories on : Stocks | Stock Markets | Ear to the ground | Ranbaxy Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Monsoon may enter weak phase again

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line